KZKevin J. Zhu

Kevin J. Zhu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kevin J. Zhu has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Transmission from Sink to Patient: An Evaluation of Sink Generated Bioaerosols and their Role in Hospital Acquired Bacterial Infections

    by JoHannah Buehrer, Megan Lott, Kevin J. Zhu, Kayla Fericy, Joshua Granek, Claudia K. Gunsch, Akhenaton-Andrew Dhafir Jones, Joe Brown, Glenn Morrison, Barbara Turpin

    Healthcare Associated Infections (HAIs) pose a significant public health risk. Hospital sinks and associated plumbing are one likely source. This study investigates bioaerosol emissions from sink P-traps during faucet operation to assess their potential role in pathogen transmission in the hospital context. We designed an aerosol chamber system with adjustable air change rate and a functioning sink meeting hospital standards. We quantified bioaerosol and large droplet emission factors from the sink, using FAmpEscherichia coli as a model for Enterobacteriaceae such as Klebsiella pneumoniae. We cultured Andersen Cascade Impactor and BioSpot sampler aerosol samples and deposition plates using MI agar, which is selective for E. coli. Across five experiments, deposition plate counts were substantial, while air samples were close to detection limits. We estimated PM5.0 bioaerosol emissions factors of 1.3 x 10-10 to 1.9 x 10-10 CFU emitted per CFU in P-trap. Large droplet emission factor was one order of magnitude larger, at 4.3 x 10-9 ± 2.8 x 10-9 CFU per CFU. Results were used to predict Klebsiella pneumoniae inhalation dose (0.78 to 1.12 CFU day-1) and inhalation infection probability (∼10-5) for 5.5 day hospital stay with colonized plumbing (air change rate 6 h-1). This translates to ∼1 infection per year for a hospital with a severe plumbing system colonization affecting ∼2000 continuously occupied rooms. For pathogens with different dose response curves, we demonstrate how infection probability via inhalation depends on dose response.

  • Open Access

    Human fecal markers in environmental waters and association with indicators of human and rodent infections in urban Salvador, Bahia, Brazil

    by Fábio Neves Souza, Kevin J. Zhu, Daiana de Oliveira, Nivison Nery Jr, Jaqueline S. Cruz, Cristina Venegas-Vargas, Joe Brown, Juan P. Aguilar Ticona, Juliet Oliveira Santana, Mitermayer Galvão Reis, et al.

    This study explores the use of human mitochondrial DNA (mtDNA) markers, specifically hCYTB484, as fecal source tracking (FST) tools for environmental surveillance in a high-density, low-income community in Salvador, Bahia, Brazil. Here, we hypothesized that hCYTB484 concentrations in wastewater would correlate with indicators of human pathogen exposure, such as viral antibody prevalence and helminth infections in rodents, both of which are potential zoonotic threats. Our study found that higher concentrations of mtDNA in wastewater were associated with increased viral exposure in humans and the presence of helminths in rodents. This suggests that fecal mtDNA could serve as a promising tool for environmental surveillance of pathogens in vulnerable communities. Our findings underscore the potential of mtDNA markers to be integrated into disease monitoring systems, particularly in resource-limited urban areas with inadequate sanitation. Implementing mtDNA-based tracking in environmental waters could strengthen early-warning systems for public health, allowing for a more proactive response to emerging health threats. Further research is needed to deepen our understanding of pathogen circulation and inform more effective public health interventions.

  • Metagenomic evaluation of the performance of passive Moore swabs for sewage monitoring relative to composite sampling over time resolved deployments

    by Gyuhyon Cha, Kevin J. Zhu, Jamie M. Fischer, Camryn I. Flores, Joe Brown, Ameet Pinto, Janet K. Hatt, Konstantinos T. Konstantinidis, Katherine E. Graham


  • Zika virus RNA persistence and recovery in water and wastewater: An approach for Zika virus surveillance in resource-constrained settings

    by Kevin Zhu, Cailee Hill, Aaron Muirhead, Mausumi Basu, Joe Brown, Margo A. Brinton, Matthew J. Hayat, Cristina Venegas-Vargas, Mitermayer G. Reis, Arnau Casanovas-Massana, et al.


  • Open Access

    Elevated Fecal Mitochondrial DNA from Symptomatic Norovirus Infections Suggests Potential Health Relevance of Human Mitochondrial DNA in Fecal Source Tracking

    by Kevin J. Zhu, Brittany Suttner, Jackie Knee, Drew Capone, Christine L. Moe, Christine E. Stauber, Kostas T. Konstantinidis, Thomas E. Wallach, Amy J. Pickering, Joe Brown

    An end goal of fecal source tracking (FST) is to provide information on risk of transmission of waterborne illnesses associated with fecal contamination. Ideally, concentrations of FST markers in ambient waters would reflect exposure risk. Human mtDNA is an FST marker that is exclusively human in origin and may be elevated in feces of individuals experiencing gastrointestinal inflammation. In this study, we examined whether human mtDNA is elevated in fecal samples from individuals with symptomatic norovirus infections using samples from the United States (US), Mozambique, and Bangladesh. We quantified hCYTB484 (human mtDNA) and HF183/BacR287 (human-associated Bacteroides) FST markers using droplet digital polymerase chain reaction. We observed the greatest difference in concentrations of hCYTB484 when comparing samples from individuals with symptomatic norovirus infections versus individuals without norovirus infections or diarrhea symptoms: log10 increase of 1.42 in US samples (3,820% increase, p-value = 0.062), 0.49 in Mozambique (308% increase, p-value = 0.061), and 0.86 in Bangladesh (648% increase, p-value = 0.035). We did not observe any trends in concentrations of HF183/BacR287 in the same samples. These results suggest concentrations of fecal mtDNA may increase during symptomatic norovirus infection and that mtDNA in environmental samples may represent an unambiguously human source-tracking marker that correlates with enteric pathogen exposure risk.